Epigenomics and Cancer Risk Factors

Dr. Marta Faryna

Dr. Marta Faryna

Dr. Marta Faryna

Dissertation 2012

Genome-wide identification of hypermethylated genes in low-grade mammary lesions as potential biomarkers in early breast cancer.

Naturwissenschaftlich-Mathematische Gesamtfakultät der Ruprecht-Karls-Universität Heidelberg.


Current affiliation


Head of Immunoreceptor Diagnostics bei BioNTech Diagnostics (formerly Theracode), Mainz, Germany

to top